Cargando…
Diversity and taxonomic distribution of bacterial biosynthetic gene clusters predicted to produce compounds with therapeutically relevant bioactivities
: Bacteria have long been a source of natural products with diverse bioactivities that have been developed into therapeutics to treat human disease. Historically, researchers have focused on a few taxa of bacteria, mainly Streptomyces and other actinomycetes. This strategy was initially highly succ...
Autores principales: | Beck, Max L, Song, Siyeon, Shuster, Isra E, Miharia, Aarzu, Walker, Allison S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548851/ https://www.ncbi.nlm.nih.gov/pubmed/37653463 http://dx.doi.org/10.1093/jimb/kuad024 |
Ejemplares similares
-
Heterologous production of cyanobacterial compounds
por: Dhakal, Dipesh, et al.
Publicado: (2021) -
Metabolic profiling as a tool for prioritizing antimicrobial compounds
por: Wu, Changsheng, et al.
Publicado: (2015) -
Traminines A and B, produced by Fusarium concentricum, inhibit oxidative phosphorylation in Saccharomyces cerevisiae mitochondria
por: Sakai, Katsuyuki, et al.
Publicado: (2021) -
Streptomyces lividans 66 produces a protease inhibitor via a tRNA-utilizing enzyme interacting with a C-minus NRPS
por: Aguilar, César, et al.
Publicado: (2023) -
Effective approaches to discover new microbial metabolites in a large strain library
por: Zdouc, Mitja M, et al.
Publicado: (2021)